In the acute lymphoblastic leukemia cell line RS4;11, apoptosis induced by the BCL-2 inhibitor venetoclax (also known as ABT-199)7,9 or standard-of-care chemotherapeutic agents is also principally mediated by BAX (Fig. 5c). Here, BCL2 is linked to acute lymphoblastic leukemia.